GeNeuro, a biopharmaceutical company developing novel treatments for neurodegenerative and autoimmune diseases such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and the severe consequences of Covid-19, (PASC, post-Covid or Long Covid), has entered into a credit agreement for a total amount of up to €25 million with the European Investment Bank (EIB), supported by […]